Clinical Trial Update: LAmbre™ II Left Atrial Appendage Occluder and Occluder Delivery System for Patients With Non-Valvular Atrial Fibrillation [NA]

View source ↗

Summary

Clinical trial update for the LAmbre II Left Atrial Appendage Occluder and Occluder Delivery System in patients with nonvalvular atrial fibrillation. The trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonvalvular Atrial Fibrillation

Snippet

Sponsor: Prince of Wales Hospital, Shatin, Hong Kong | Conditions: Non Valvular Atrial Fibrillation | NA | Status: NOT_YET_RECRUITING